Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP-MR Spectroscopic Imaging in Pancreatic Cysts
NCT05873699Phase 1Suspended
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hyperpolarized 13C-pyruvate in pancreatic cyst, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Incidence of Adverse Events at 1 year. Started Aug 2023; status: suspended.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
pancreatic cyst
Beyond the preview
Go deeper on NCT05873699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05873699.